| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $732.0M | +13.6% |
| Cost of Revenue | $358.1M | +22.1% |
| Gross Profit | $373.9M | +6.5% |
| R&D Expense | $73.9M | +0.2% |
| SG&A Expense | $56.7M | +10.1% |
| Operating Income | $205.4M | +4.3% |
| Pre-tax Income | $189.8M | +10.7% |
| Income Tax | $29.7M | -6.8% |
| Net Income | $159.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $151.6M | +5.1% |
| Short-term Investments | $70.0M | -37.8% |
| Accounts Receivable | $136.3M | +18.6% |
| Inventory | $153.7M | +45.3% |
| Current Assets | $534.1M | +9.1% |
| Total Assets | $1.58B | +4.3% |
| Current Liabilities | $173.8M | -22.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $213.4M | +16.3% |
| Capital Expenditures | $41.0M | +7.5% |
| Investing Cash Flow | -$124.9M | +80.8% |
| Financing Cash Flow | -$81.0M | -117.8% |
| Free Cash Flow | $172.3M | +18.6% |
| +16.0% |
| EPS (Basic) | $3.29 | +15.4% |
| EPS (Diluted) | $3.06 | +17.7% |
| Long-term Debt |
| $613.5M |
| +1.7% |
| Total Liabilities | $845.2M | -3.2% |
| Stockholders' Equity | $732.3M | +14.5% |